Next |
home / stock / imnm / imnm message board
Subject | By | Source | When |
---|---|---|---|
Ha, sold in fall of 21 for $25. | wiwineguy | investorshub | 06/29/2023 1:42:46 PM |
$IMNM: Now 10.40 !!!!!!!!!!! | makinezmoney | investorshub | 06/29/2023 1:13:11 PM |
$IMNM: Boooommmmmmmmmmmmmmm.......now $8.50 | makinezmoney | investorshub | 06/29/2023 1:07:40 PM |
Immunome and Morphimmune Announce Definitive Merger Agreement and | Awl416 | investorshub | 06/29/2023 1:03:28 PM |
Good read | Major_Bankz | investorshub | 06/27/2023 4:07:56 PM |
where is the squeeze? | Major_Bankz | investorshub | 06/17/2023 6:22:06 AM |
is it bear time? Or do we go bull? | Major_Bankz | investorshub | 06/15/2023 5:35:24 AM |
bears and bulls | Pedro2004 | investorshub | 06/10/2023 8:04:58 AM |
are we finally gonna see some action | Pedro2004 | investorshub | 06/06/2023 3:31:04 AM |
$IMNM short squeeze | Pedro2004 | investorshub | 06/04/2023 3:45:14 AM |
AviseAnalytics: CAN IMMUNOME BOUNCE BACK FROM CLINICAL HOLD ON IMM-BCP-01? $IMNM Immunome, Inc. | AviseAnalytics | investorshangout | 01/17/2022 12:20:41 PM |
you don't know crap majorbankz. | wiwineguy | investorshub | 07/30/2021 7:16:41 PM |
They cannot dilute on the bid. Only the ask | Harbor6460 | investorshub | 07/24/2021 3:48:30 PM |
Pulled down to under $20.00 | Pedro2004 | investorshub | 07/20/2021 3:41:58 PM |
They pulled this down to under $21.00 | Pedro2004 | investorshub | 07/20/2021 3:22:00 PM |
$22.50 U worry too much, should be $25+ | Major_Bankz | investorshub | 07/20/2021 3:04:20 PM |
I thought this was going to break today. | Pedro2004 | investorshub | 07/20/2021 2:42:16 PM |
This run could have broke $30 today. But | Pedro2004 | investorshub | 07/20/2021 2:40:29 PM |
yep, shorties portfolio will get destroyed here. | Major_Bankz | investorshub | 07/20/2021 2:40:10 PM |
The dilution is going to kill this run. | Pedro2004 | investorshub | 07/20/2021 2:38:33 PM |
News, Short Squeeze, Breakout and More Instantly...
Immunome Inc. Company Name:
IMNM Stock Symbol:
NASDAQ Market:
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the appointment of Sandra M. Swain, M.D., to its Board of Directors. Dr. Swain has over 30 years of oncology clinical research experience and ha...
2024-04-22 10:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that it will present preclinical data for IM-3050, the company’s lead lutetium-177 radioligand therapy (RLT) targeting fibroblast activat...